nalidixic acid has been researched along with Endocarditis, Bacterial in 7 studies
Endocarditis, Bacterial: Inflammation of the ENDOCARDIUM caused by BACTERIA that entered the bloodstream. The strains of bacteria vary with predisposing factors, such as CONGENITAL HEART DEFECTS; HEART VALVE DISEASES; HEART VALVE PROSTHESIS IMPLANTATION; or intravenous drug use.
| Excerpt | Relevance | Reference |
|---|---|---|
| " From the published evidence, the most promising associations are, for staphylococcal infections, gentamicin, erythromycin, kanamycin and fusidic acid." | 4.76 | Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence. ( Fowst, G; Nessi, R, 1979) |
| "Pefloxacin was also as effective as vancomycin in reducing vegetation titers and mortality rate in animals with endocarditis caused by a methicillin-resistant strain." | 1.27 | Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus. ( Chambers, HF; Hackbarth, CJ; Sande, MA; Scott, KG; Sullam, PM; Täuber, MG, 1985) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Contrepois, A | 1 |
| Daldoss, C | 1 |
| Pangon, B | 1 |
| Garaud, JJ | 1 |
| Kecir, M | 1 |
| Sarrazin, C | 1 |
| Vallois, JM | 1 |
| Carbon, C | 1 |
| Czieschnek, R | 1 |
| Nessi, R | 1 |
| Fowst, G | 1 |
| Sorice, F | 1 |
| Ortona, L | 1 |
| Pizzigallo, E | 1 |
| Sullam, PM | 1 |
| Täuber, MG | 1 |
| Hackbarth, CJ | 1 |
| Chambers, HF | 1 |
| Scott, KG | 1 |
| Sande, MA | 1 |
| Williams, TW | 1 |
| Sailer, JE | 1 |
| Viroslav, J | 1 |
| Knight, V | 1 |
| Glasgow, N | 1 |
| Moreland, N | 1 |
| McCracken, GH | 1 |
| Eichenwald, HF | 1 |
| Nelson, JD | 1 |
1 review available for nalidixic acid and Endocarditis, Bacterial
| Article | Year |
|---|---|
Clinical use of rifampicin in combination for non-mycobacterial infections: a survey of published evidence.
Topics: Amphotericin B; Cephalosporins; Chloramphenicol; Colistin; Drug Therapy, Combination; Endocarditis, | 1979 |
6 other studies available for nalidixic acid and Endocarditis, Bacterial
| Article | Year |
|---|---|
Pefloxacin in rabbits: protein binding, extravascular diffusion, urinary excretion and bactericidal effect in experimental endocarditis.
Topics: Animals; Anti-Infective Agents; Diffusion; Endocarditis, Bacterial; Escherichia coli Infections; Fur | 1984 |
[Serratia marcescens].
Topics: Arthritis; Bacteriocins; Bacteriology; Cross Infection; Disinfection; Endocarditis, Bacterial; Genta | 1981 |
[Further aspects of combination antibiotic therapy. Critical review and personal case studies].
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; Brucellosis; Drug Interactions; Drug Thera | 1975 |
Pefloxacin therapy for experimental endocarditis caused by methicillin-susceptible or methicillin-resistant strains of Staphylococcus aureus.
Topics: Animals; Anti-Bacterial Agents; Endocarditis, Bacterial; Methicillin; Microbial Sensitivity Tests; N | 1985 |
Serratia marcescens as a postoperative pathogen.
Topics: Ampicillin; Anti-Bacterial Agents; Carbenicillin; Cephalothin; Chloramphenicol; Endocarditis, Bacter | 1971 |
Antimicrobial therapy in theory and practice. II. Clinical approach to antimicrobial therapy.
Topics: Ampicillin; Anti-Bacterial Agents; Anti-Infective Agents; Arthritis, Juvenile; Bronchopneumonia; Chi | 1969 |